Pure Global AI
NCT06298617Completed

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis

Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis: A Comparative Study Versus Exploratory Laparoscopy
Benha UniversityClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Endometriosis
Drug/Device/Intervention
Diagnostic laparoscopy
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Benha University
Location
Banhā, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2023
End date
Dec 25, 2023
Enrollment
88 participants
Primary outcome

Indices' ability to predict EM stage

Summary

Endometriosis (EMs) is one of the commonest chronic inflammatory disorder affecting women and
 is characterized by the presence and growth of endometrial-like glandular epithelial and
 stromal cells outside the uterus leading to multiple clinical symptoms affecting patients
 quality of life and fertility with high recurrence rate . The systemic immune inflammatory
 index (SII) and systemic inflammatory response index (SIRI) are documented as prognostic
 serum biomarker in many kinds of cancer and for the need and outcomes of adjuvant therapies
 for various cancers .

ICD-10 classifications
EndometriosisOther endometriosisEndometriosis, unspecifiedEndometriosis of uterusEndometriosis of ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06298617
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06298617 through Pure Global AI's free database. This phase not specified trial is sponsored by Benha University and is currently Completed. The study focuses on Endometriosis. Target enrollment is 88 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.